Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Appointed director
CC transcript
ENZO BIOCHEM INC (ENZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/24/2023 8-K Quarterly results
07/17/2023 8-K Other Events  Interactive Data
07/10/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT"
06/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION OF THE COMPANY"
05/08/2023 8-K Other Events  Interactive Data
04/13/2023 8-K Quarterly results
04/05/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "CREDIT AGREEMENT"
03/16/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ASSET PURCHASE AGREEMENT dated as of March 16, 2023 by and among LABORATORY CORPORATION OF AMERICA HOLDINGS, Enzo Clinical Labs, Inc.",
"Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp"
02/03/2023 8-K Quarterly results
11/03/2022 8-K Quarterly results
10/20/2022 8-K Quarterly results
04/27/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENZO BIOCHEM, INC",
"AMENDED AND RESTATED BY-LAWS OF ENZO BIOCHEM, INC"
04/08/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/30/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "*** 12 You acknowledge and agree that you have read and understand this Employment agreement and you voluntarily agree to the terms and conditions contained herein. We look forward to you joining the Company. If you accept this offer of employment, please sign and return to me this Employment Agreement attached by no later than March 27, 2022 or this offer shall expire.",
"EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement , dated as of March 24, 2022, made between Enzo Biochem, Inc., a New York corporation, with its principal office at 527 Madison Avenue, New York, New York 10022 and Kara Cannon . Whereas, Executive is currently a full-time employee of the Company; and Whereas, the Company desires for Executive to continue to provide services to the Company, and wishes to provide Executive with certain compensation and benefits in return for such employment services; and Whereas, Executive wishes to continue to be employed by the Company and to provide personal services to the Company in return for certain compensation and benefits; Now, Therefore, in consideration of the mutual promises and covenants contained herein and for other good and ...",
"First Amended and Restated Employment Agreement between Enzo Biochem, Inc. and Hamid Erfanian, effective as of March 24, 2022",
"Enzo Biochem Announces Appointments of David Bench and Kara Cannon to New Executive Management Positions"
03/18/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Amendment No. 2 to Amended and Restated By-Laws of Enzo Biochem, Inc., effective as of March 11, 2022"
03/07/2022 8-K Quarterly results
01/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/04/2022 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Exhibit A",
"Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem’ s Board of Directors"
10/18/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIAGNOSTIC PLATFORMS Dr. Elazar Rabbani to remain Chairperson of the Board and will assume new role as Chief Scientific Officer , October 18, 2021 -- Enzo Biochem, Inc. , a leading biosciences and diagnostics company, announced today the appointment of Hamid Erfanian as Chief Executive Officer. Following the succession plan announced in March and the engagement of Korn Ferry, Dr. Elazar Rabbani remains Chairperson of the Board of Directors and will assume the role of Chief Scientific Officer of the Company. Mr. Erfanian brings over 28 years of experience as a seasoned healthcare executive specializing in the diagnostic, medical devices, and life sciences industry. His demonstra..."
06/14/2021 8-K Quarterly results
06/11/2021 8-K Quarterly results
03/19/2021 8-K Quarterly results
03/16/2021 8-K Quarterly results
01/08/2021 8-K Quarterly results
01/06/2021 8-K Investor presentation
Docs: "Presentation materials to be used by officers of the Company",
"ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS"
12/17/2020 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment",
"Presentation materials for Key Opinion Leader call on December 17, 2020"
12/14/2020 8-K Quarterly results
Docs: "Conference call and live webcast scheduled for today, Wednesday, December 9, 2020 at 4:30 pm"
11/25/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS , November 25, 2020 – Enzo Biochem, Inc. , a leading biosciences and diagnostics company, announced today that Ian B. Walters, MD, has been appointed to the Company’ s Board of Directors effective immediately. Dr. Walters is an experienced entrepreneur and drug developer with leadership in the development of over 30 drugs in multiple therapeutic areas involving diverse technologies, leading to five new oncology drug approvals. His previous positions include Executive Director of Global Oncology Clinical Research and Business Development for Bristol-Myers Squibb, and Medical Director at Millennium Pharmaceuticals. Dr. Walters currently is CEO and Director of Portage Biotech, a publicly traded clinical stage ..."
11/23/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS"
11/16/2020 8-K Resignation/termination of a director
06/25/2020 8-K Quarterly results
06/08/2020 8-K Quarterly results
Docs: "Press Release of Enzo Biochem, Inc."
04/24/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "U.S. Small Business Administration PAYCHECK PROTECTION PROGRAM LOAN NOTE it has been formed. B. Borrower is duly authorized to transact business in all other states in which Borrower is doing business, having obtained all necessary filings, governmental licenses and approvals for each state in which Borrower is doing business; Borrower’ s execution, delivery, and performance of this Note and any Loan Documents have been duly authorized by all necessary action by Borrower and do not conflict with, result in a violation of, or constitute a default under any provision of Borrower’ s articles of incorporation or organization, or bylaws, or any agreement or other instrument binding upon Borrower, or any law, governmental regulation, court decree, or order applicable to Borrower or to Borrower’ ..."
04/09/2020 8-K Regulation FD Disclosure, Other Events
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy